Takeda Pharmaceutical
275 hedge funds and large institutions have $772M invested in Takeda Pharmaceutical in 2022 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 95 increasing their positions, 67 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
275
Holders Change
-5
Holders Change %
-1.79%
% of All Funds
4.76%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
36
Increased
95
Reduced
67
Closed
32
Calls
$26.5M
Puts
$7.22M
Net Calls
+$19.3M
Net Calls Change
-$15.1M
Top Buyers
| 1 |
CI
Clal Insurance
Tel-Aviv,
Israel
|
$56.3M |
| 2 |
American Century Companies
Kansas City,
Missouri
|
$21.5M |
| 3 |
ECM
Endurant Capital Management
San Mateo,
California
|
$14.3M |
| 4 |
Goldman Sachs
New York
|
$55.4M |
| 5 |
LP
LMR Partners
London,
United Kingdom
|
$7.66M |
Top Sellers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
$3.33M |
| 2 |
Russell Investments Group
London,
United Kingdom
|
$1.38M |
| 3 |
HT
HAP Trading
New York
|
$0 |
| 4 |
Millennium Management
New York
|
$13M |
| 5 |
Jane Street
New York
|
$5.37M |
